Kick off 2026 with a competitive edge at PACK EXPO East. Register now!
Get a jump on your 2026 goals at PACK EXPO East. Put projects in motion, accelerate timelines and solve challenges—all in one trip to Philadelphia.

New drug warning

Johnson & Johnson said it plans to change the package insert of its second-best selling medicine, the antipsychotic drug Risperdal, to warn of a possible increased risk of stroke for elderly patients.

The company also will send letters to thousands of U.S. physicians notifying them of the risk similar to a letter it sent to Canadian physicians and pharmacists last October. The drug is approved only for schizophrenia, but is often used with elderly patients suffering from dementia and Alzheimer’s.

Annual Outlook Report: Automation & Robotics
What's in store for CPGs in 2025 and beyond? Packaging World editors explore the survey responses from 118 brand owners, CPG, and FMCG Packaging World readers for its new Annual Outlook Report.
Download
Annual Outlook Report: Automation & Robotics
Annual Outlook Report: Workforce
Hiring remains a major challenge in packaging, with 78% struggling to fill unskilled roles and 84% lacking experienced workers. As automation grows, companies must rethink hiring and training. Download the full report for key insights.
Download Now
Annual Outlook Report: Workforce